Table 2.
Sources of Anxiety in CLL patients1
| Overall N=1482 |
Low Risk2 N=537 |
Intermediate Risk2 N=459 |
High Risk2 N=209 |
P value | |
|---|---|---|---|---|---|
| Concern about the implications of my CLL for my family/loved ones | 5.1 | 4.0 | 5.0 | 7.0 | <0.001 |
| Uncertainty about whether my CLL will progress | 4.3 | 3.9 | 4.4 | 5.4 | <0.001 |
| Concern about the side effects of treatment for my CLL | 4.1 | 3.3 | 4.3 | 5.6 | <0.001 |
| Concern my children or relatives may also develop CLL | 3.6 | 3.5 | 3.8 | 3.9 | 0.396 |
| Generalized worry about having CLL | 3.6 | 3.1 | 3.6 | 4.6 | <0.001 |
| Living with symptoms related to CLL (fatigue, weight loss, night sweats, infections) | 3.5 | 2.0 | 3.0 | 6.0 | <0.001 |
1
Patients were asked to rate how much each item negatively affected their quality of life on a 0–10 Likert scale where 0 = “no effect on my quality of life” and 10 = “major negative effect on my QOL”. Items are shown in hierarchical order of importance to CLL patients based on mean scores.
2
Risk refers to patients stage using the modified Rai risk categorization28